Drugs / [18F]AZAN
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05462340 | Aug 2022 → Jan 2025 | schizophrenia | Washington University School of Medicine | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | [18F]AZAN | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05462340 ↗ |